Login |
ProfileLoke Diagnostics ApS is specialized in production of biotechnological products: recombinant proteins, defined peptides, modified peptides and peptide libraries. Combination of these products are used in contract-based projects for development of diagnostic tests, and for vaccine - and drug development. Loke Diagnostics ApS is specialized in production of specific bacterial antigens for use in ELISA-based assays and for production of specific antibodies. Antigen production is based on recombinant DNA technology and peptide synthesis. We are specialized in production of peptide antigens that have high binding affinity to ELISA plates and to serum antibodies. Antibodies are produced from recombinant proteins or peptides. The antibodies are tested for reactivity with native microbial surface, for reactivity in paraffin embedded sectioned tissue samples, and for reactivity in ELISA and immunoblotting. Loke Diagnostics ApS has expertise in synthesis of peptides, modified peptides and solid-phase peptide libraries used for combinatorial chemistry and peptide-drug development. The scientists who started Loke Diagnostics have backgrounds as University professors: The director, Svend Birkelund, is professor and Gunna Christiansen is professor in medical molecular biology both at Department of Medical Microbiology & Immunology, University of Aarhus. Arne Holm was professor at Department of Chemistry, The Royal Veterinary and Agricultural University, Copenhagen, Denmark. Currently Loke Diagnostics is involved in the development of diagnostic tools for analyzing infections caused by Chlamydia and Mycoplasma, in the development of chlamydial vaccines, and in optimizing peptide drugs. Loke Diagnostics ApS works as developer based on contracts with other partners. Loke Diagnostics seeks collaboration with companies involved in the development of microbial diagnostic tests, vaccine and drug development. |